investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Illuminating the Druggable Genome
Tudor Oprea
7 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Larry A Sklar
University of New Mexico
Albuquerque, United States
Stephen C Schurer
University of Miami
Coral Gables, United States
Anton M Simeonov
National Center for Advancing Translational Sciences (NIH)
Rockville, United States
John Overington
European Molecular Biology Laboratory
Heidelberg, Germany
Lars Juhl Jensen
Novo Nordisk (Denmark)
Copenhagen, Denmark
Soren Brunak
Novo Nordisk (Denmark)
Copenhagen, Denmark
Anne Hersey
European Bioinformatics Institute
Cambridge, United Kingdom
Tudor Oprea
University of New Mexico
Albuquerque, United States
Related projects
Peter J Burke
High-throughput on-chip platform for interrogation of mitochondrial membrane potential and apoptosis
All cancers but non-melanoma skin cancer
Steven J. Brill
Mechanism of the BLM/Sgs1 Helicase Complex
All cancers but non-melanoma skin cancer
Raymond J Monnat
Molecular Determinants of Cancer Therapeutic Response
All cancers but non-melanoma skin cancer
Nicholas Restifo
Building on the Success of the Adoptive Immunotherapy of Cancer
All cancers but non-melanoma skin cancer
Carol Prives
Regulation of the p53 Tumor Suppressor Protein
All cancers but non-melanoma skin cancer
William C Hahn
Systematic identification of oncogenic KRAS synthetic lethal interactions
All cancers but non-melanoma skin cancer
Gavin J Sherlock
Molecular Characterization of Adaptive Evolution
All cancers but non-melanoma skin cancer
Till Bartke
Molecular Mechanisms of Chromatin Regulation by DNA and Histone Modifications and Epigenetic Reader Molecules
All cancers but non-melanoma skin cancer
Peter Sarnow
Modulation of internal ribosome entry by ribosomal protein RPS25
All cancers but non-melanoma skin cancer
